Deregulations in the Cyclin-Dependent Kinase-9-Related Pathway in Cancer: Implications for Drug Discovery and Development

Figure 2

The Cdk9/cyclin T1 complex. The arrow depicts a yellow line, which shows the binding interface between Cdk9 and cyclin T1.